Price (delayed)
$26.67
Market cap
$2.5B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.35
Enterprise value
$2.48B
Scholar Rock is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays
There are no recent dividends present for SRRK.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.